Schering Nasonex patents
Executive Summary
Schering-Plough has a patent (no. 6,127,353) on mometasone furoate monohydrate, the active ingredient in the nasal inhaler Nasonex, that runs until 2018 (including a pediatric extension). The basic patent on mometasone furoate (no. 4,472,393) expires in March 2002. Both patents are listed in the FDA "Orange Book" for Nasonex (1"The Pink Sheet" Jan. 14, p. 8)...